Cargando…
Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine
Numerous human infections with avian influenza viruses in Asia in recent years have raised the concern that the next influenza pandemic is imminent. The most effective way to combat influenza is through the vaccination of the public. However, a minimum of 3–6 months is needed to develop an influenza...
Autores principales: | Wang, Keyang, Holtz, Kathleen M., Anderson, Karl, Chubet, Richard, Mahmoud, Wafaa, Cox, Manon M.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115642/ https://www.ncbi.nlm.nih.gov/pubmed/16310896 http://dx.doi.org/10.1016/j.vaccine.2005.11.005 |
Ejemplares similares
-
FluBlok, a recombinant hemagglutinin influenza vaccine
por: Cox, Manon M.J., et al.
Publicado: (2008) -
One step closer to a universal influenza A vaccine?
por: Poon, Leo LM
Publicado: (2011) -
A Step Closer to Meeting the Threat of Avian Influenza
por: Schultz-Cherry, Stacey, et al.
Publicado: (2006) -
Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions
por: Mittal, Nidhi, et al.
Publicado: (2021) -
Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant
por: McPherson, Clifton, et al.
Publicado: (2015)